Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 11:25 PM
Ignite Modification Date:
2025-12-24 @ 11:25 PM
NCT ID:
NCT05153356
Eligibility Criteria:
Inclusion Criteria:
* PD as defined by the UK Brain Bank Criteria
* Disease duration between 2-13 years
* Aged 35-68 years
* Hoehn \& Yahr stage 3 or less when in the levodopa-"ON" state
Exclusion Criteria:
* Atypical parkinsonism including 18F-dopa PET patterns consistent with this
* MMSE score of \< 24 or evidence for dementia using DSM-IV criteria
* Unable to do normal copying of interlocking pentagons and semantic fluency score \<20 over 90 secs
* Ongoing major medical or psychiatric disorder including depression and psychosis
* Other concomitant treatment with neuroleptics
* Significant drug induced dyskinesias (\>2 for any body part on the AIMS scale)
* Previous neurosurgery Unable to be imaged using MRI
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
35 Years
Maximum Age:
68 Years
Study:
NCT05153356
Study Brief:
Protocol Section:
NCT05153356